血清抗转录中介因子1-γ自身抗体水平与皮肌炎患者临床、病理特征及结局的相关性
研究纳入87例免疫印迹法筛查抗TIF1-γ抗体阳性的成人皮肌炎患者,用ELISA检测抗体水平,52例完成肌肉活检。80例ELISA确认阳性(CAM 30例,非CAM 50例)。抗体水平与疾病活动度相关,在非CAM患者中与肌肉活检总评分、肌纤维评分和炎性浸润评分正相关,但在CAM患者中无此关联;高抗体水平CAM患者生存率低于低水平者,非CAM组高低水平间生存率无差异。
要点
- 抗TIF1-γ抗体水平与皮肌炎疾病活动度评分相关。
- 非CAM患者中抗体水平与肌肉活检总评分、肌纤维评分和炎性浸润评分正相关,CAM患者中无此关联。
- 高抗体水平CAM患者生存率低于低水平者,非CAM组高低水平间生存率无差异。
核心结论
- 抗TIF1-γ抗体水平与疾病活动度、肌肉组织病理损伤及结局的不同关联提示,伴或不伴肿瘤的皮肌炎可能涉及不同发病机制。
研究设计与样本
- 纳入87例经免疫印迹法筛查抗TIF1-γ抗体阳性的成人皮肌炎患者,用ELISA检测抗体存在与水平,52例患者获取肌肉活检标本行免疫组化观察MHC-I、CD3、CD20和C5b-9,并评估肌肉活检评分与疾病活动度。
主要发现
- 80例经ELISA确认抗TIF1-γ抗体阳性,其中肿瘤相关肌炎(CAM)30例、非CAM 50例。
- CAM组与非CAM组血清抗TIF1-γ抗体水平无显著差异。
- 63.9%的非CAM患者呈现经典皮肌炎病理表型;CAM患者肌肉活检表型为经典皮肌炎25%、免疫介导坏死性肌病25%、非特异性肌炎32.3%、正常18%。
- 非CAM患者中抗TIF1-γ抗体水平与肌肉活检总评分、肌纤维评分和炎性浸润评分正相关,CAM患者中无此关联。
- 高抗TIF1-γ抗体水平的CAM患者生存率低于低水平者,非CAM组高低水平间生存率无差异。
关键数值与推荐
- 抗TIF1-γ抗体水平与疾病活动度评分相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the association of the serum levels of anti-transcriptional intermediary factor 1 (TIF1)-γ autoantibodies with the clinical and pathological characteristics, as well as the prognosis of adult patients with dermatomyositis (DM). METHODS: Eighty-seven adult DM patients with anti-TIF1-γ autoantibodies positive screened by immunoblotting assay were enrolled in the study. The presence and levels of anti-TIF1-γ autoantibodies were examined through enzyme-linked immunosorbent assay (ELISA). Muscle biopsy specimens were obtained from 52 patients, and immunohistochemistry was performed to visualize major histocompatibility complex (MHC)-I, CD3, CD20 and C5b-9. Muscle biopsy scores and disease activity were evaluated. RESULTS: A total of 80 patients were positive for anti-TIF1-γ autoantibodies confirmed by ELISA assay, including 30 cancer-associated myositis (CAM) and 50 non-CAM. Serum levels of anti-TIF1-γ autoantibodies did not significantly differ between the CAM and non-CAM groups. The levels of anti-TIF1-γ were associated with disease activity scores. A total of 63.9% of non-CAM patients displayed a classical DM pathological phenotype. Conversely, CAM patients presented with classical DM (25%), immune-mediated necrotizing myopathy (25%), non-specific myositis (32.3%), and normal (18%) phenotypes of muscle biopsy. Anti-TIF1-γ autoantibody levels were positively associated with muscle biopsy total scores, muscle fiber scores and inflammatory infiltration scores in the non-CAM patients but not in the CAM patients. The survival rate of CAM patients presenting with high anti-TIF1-γ autoantibody levels was lower than that of patients with low levels. However, no difference in survival rate was observed in the non-CAM group between high and low autoantibody levels. CONCLUSION: The distinct associations of anti-TIF1-γ autoantibody levels with disease activity, muscle histopathology damage and outcome indicated that different pathogenesis might be involved in DM with or without cancer.
引用
- Zhang L, Yang H, Yang H, et al. Serum levels of anti-transcriptional intermediary factor 1-γ autoantibody associated with the clinical, pathological characteristics and outcomes of patients with dermatomyositis. Semin Arthritis Rheum. 2022. PMID: 35489170. doi:10.1016/j.semarthrit.2022.152011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。